Enzychem Lifesciences Corporation (KOSDAQ: 183490)
South Korea
· Delayed Price · Currency is KRW 1,277.00
+19.00 (1.51%)
Nov 15, 2024, 9:00 AM KST
Enzychem Lifesciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 84,826 | 76,039 | 26,638 | 22,975 | 25,818 | 31,469 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | - | Upgrade
|
| Revenue | 84,826 | 76,039 | 26,638 | 22,975 | 25,818 | 31,469 | Upgrade
|
| Revenue Growth (YoY) | 87.09% | 185.46% | 15.94% | -11.01% | -17.96% | 1.40% | Upgrade
|
| Cost of Revenue | 79,735 | 71,691 | 24,221 | 22,689 | 23,999 | 28,804 | Upgrade
|
| Gross Profit | 5,091 | 4,348 | 2,416 | 286.72 | 1,820 | 2,664 | Upgrade
|
| Selling, General & Admin | 12,729 | 12,017 | 9,834 | 10,859 | 7,697 | 6,933 | Upgrade
|
| Research & Development | 4,627 | 5,434 | 6,558 | 9,501 | 12,865 | 11,443 | Upgrade
|
| Operating Expenses | 18,725 | 19,081 | 17,078 | 21,040 | 20,927 | 19,067 | Upgrade
|
| Operating Income | -13,633 | -14,733 | -14,662 | -20,754 | -19,107 | -16,402 | Upgrade
|
| Interest Expense | -258.43 | -620.09 | -10,030 | -9,508 | -1,430 | -51.45 | Upgrade
|
| Interest & Investment Income | 5,676 | 5,489 | 3,976 | 963.71 | 552.02 | 691.24 | Upgrade
|
| Earnings From Equity Investments | -249.94 | 26.87 | -13.64 | -445.14 | -378.53 | 704.7 | Upgrade
|
| Currency Exchange Gain (Loss) | 58.75 | -34.38 | -164.71 | -60.59 | 28.7 | -54.41 | Upgrade
|
| Other Non Operating Income (Expenses) | 99.9 | 41.19 | -7.09 | 292.36 | 1,422 | -1,582 | Upgrade
|
| EBT Excluding Unusual Items | -8,306 | -9,830 | -20,901 | -29,512 | -18,913 | -16,694 | Upgrade
|
| Gain (Loss) on Sale of Investments | -924.6 | 3.65 | 3.57 | 4.39 | -258.53 | 18.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | -19.51 | -19.5 | 8.12 | -13.27 | - | - | Upgrade
|
| Asset Writedown | -183.3 | -32.74 | -4,692 | 16.05 | -60.09 | -0.06 | Upgrade
|
| Pretax Income | -9,434 | -9,879 | -25,581 | -29,504 | -19,232 | -16,676 | Upgrade
|
| Income Tax Expense | -488.82 | -476.3 | -488.27 | -1,640 | -1,725 | 203.55 | Upgrade
|
| Earnings From Continuing Operations | -8,945 | -9,403 | -25,093 | -27,865 | -17,507 | -16,879 | Upgrade
|
| Minority Interest in Earnings | 29.18 | 76.24 | - | - | - | - | Upgrade
|
| Net Income | -8,916 | -9,326 | -25,093 | -27,865 | -17,507 | -16,879 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | -159.59 | -941.77 | -63.66 | -435.05 | Upgrade
|
| Net Income to Common | -8,916 | -9,326 | -24,934 | -26,923 | -17,443 | -16,444 | Upgrade
|
| Shares Outstanding (Basic) | 84 | 85 | 79 | 50 | 49 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 84 | 85 | 79 | 50 | 49 | 47 | Upgrade
|
| Shares Change (YoY) | -26.86% | 7.75% | 56.10% | 3.93% | 3.53% | 3.34% | Upgrade
|
| EPS (Basic) | -105.69 | -109.81 | -316.34 | -533.20 | -359.04 | -350.41 | Upgrade
|
| EPS (Diluted) | -105.88 | -110.00 | -316.34 | -533.20 | -359.04 | -350.41 | Upgrade
|
| Free Cash Flow | -9,251 | -12,506 | -22,277 | -24,407 | -16,857 | -17,927 | Upgrade
|
| Free Cash Flow Per Share | -109.66 | -147.25 | -282.63 | -483.37 | -346.96 | -382.02 | Upgrade
|
| Gross Margin | 6.00% | 5.72% | 9.07% | 1.25% | 7.05% | 8.47% | Upgrade
|
| Operating Margin | -16.07% | -19.38% | -55.04% | -90.33% | -74.01% | -52.12% | Upgrade
|
| Profit Margin | -10.51% | -12.27% | -93.60% | -117.18% | -67.56% | -52.26% | Upgrade
|
| Free Cash Flow Margin | -10.91% | -16.45% | -83.63% | -106.23% | -65.29% | -56.97% | Upgrade
|
| EBITDA | -10,123 | -11,221 | -12,273 | -18,643 | -17,072 | -14,456 | Upgrade
|
| EBITDA Margin | -11.93% | -14.76% | -46.07% | -81.14% | -66.12% | -45.94% | Upgrade
|
| D&A For EBITDA | 3,510 | 3,512 | 2,389 | 2,111 | 2,036 | 1,947 | Upgrade
|
| EBIT | -13,633 | -14,733 | -14,662 | -20,754 | -19,107 | -16,402 | Upgrade
|
| EBIT Margin | -16.07% | -19.38% | -55.04% | -90.33% | -74.01% | -52.12% | Upgrade
|
| Advertising Expenses | - | 299.56 | 456.54 | 443.63 | 279.89 | 419.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.